EGFR and breast carcinoma: For example, G-1 stimulates proliferation in primary breast cancer tissue and the GPER antagonist G-36 completely inhibits G-1-mediated proliferation (47); G-1 enhances ovarian cancer cell proliferation via EGFR and Akt signaling pathways (48).